PMID- 38148106
OWN - NLM
STAT- MEDLINE
DCOM- 20240502
LR  - 20240505
IS  - 2093-5978 (Electronic)
IS  - 2093-596X (Print)
IS  - 2093-596X (Linking)
VI  - 39
IP  - 2
DP  - 2024 Apr
TI  - Effectiveness of a Social Networking Site Based Automatic Mobile Message 
      Providing System on Glycemic Control in Patients with Type 2 Diabetes Mellitus.
PG  - 344-352
LID - 10.3803/EnM.2023.1871 [doi]
AB  - BACKGRUOUND: This study investigated the effectiveness of a social networking 
      site (SNS)-based automatic mobile message providing system on glycemic control in 
      patients with type 2 diabetes mellitus (T2DM). METHODS: A 3-month, randomized, 
      open-label, controlled, parallel-group trial was conducted. One hundred and ten 
      participants with T2DM were randomized to a mobile message system (MMS) (n=55) or 
      control group (n=55). The MMS group received protocolbased automated messages two 
      times per day for 10 weeks regarding diabetes self-management through KakaoTalk 
      SNS messenger. The primary outcome was the difference in the change in glycated 
      hemoglobin (HbA1c) levels (%) from baseline to week 12. RESULTS: HbA1c levels 
      were more markedly decreased in the MMS group (8.4%+/-0.7% to 8.0%+/-1.1%) than in 
      the control group (8.5%+/-0.8% to 8.4%+/-0.8%), resulting in a significant 
      between-group difference (P=0.027). No differences were observed in changes in 
      fasting glucose levels, lipid profiles, and the number of participants who 
      experienced hypoglycemia, or in changes in lifestyle behavior between groups. 
      However, the self-monitoring of blood glucose frequency was significantly 
      increased in the MMS group compared to the control group (P=0.003). In addition, 
      sleep duration was increased in the MMS group, but was not changed in the control 
      group. CONCLUSION: An SNS-based automatic mobile message providing system was 
      effective in improving glycemic control in patients in T2DM. Studies which based 
      on a more individualized protocol, and investigate longer beneficial effect and 
      sustainability will be required in the future.
FAU - Kim, Kyuho
AU  - Kim K
AD  - Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The 
      Catholic University of Korea, Seoul, Korea.
FAU - Yun, Jae-Seung
AU  - Yun JS
AD  - Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The 
      Catholic University of Korea, Seoul, Korea.
FAU - Lee, Joonyub
AU  - Lee J
AD  - Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, 
      The Catholic University of Korea, Seoul, Korea.
FAU - Yang, Yeoree
AU  - Yang Y
AD  - Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, 
      The Catholic University of Korea, Seoul, Korea.
FAU - Lee, Minhan
AU  - Lee M
AD  - iKooB Inc., Seoul, Korea.
FAU - Ahn, Yu-Bae
AU  - Ahn YB
AD  - Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The 
      Catholic University of Korea, Seoul, Korea.
FAU - Cho, Jae Hyoung
AU  - Cho JH
AD  - Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, 
      The Catholic University of Korea, Seoul, Korea.
AD  - iKooB Inc., Seoul, Korea.
FAU - Ko, Seung-Hyun
AU  - Ko SH
AD  - Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The 
      Catholic University of Korea, Seoul, Korea.
LA  - eng
GR  - Korea Health Industry Development Institute/
GR  - HI23C0693/Ministry of Health and Welfare/
PT  - Journal Article
PT  - Randomized Controlled Trial
PT  - Research Support, Non-U.S. Gov't
DEP - 20231227
PL  - Korea (South)
TA  - Endocrinol Metab (Seoul)
JT  - Endocrinology and metabolism (Seoul, Korea)
JID - 101554139
RN  - 0 (Glycated Hemoglobin)
RN  - 0 (Blood Glucose)
RN  - 0 (hemoglobin A1c protein, human)
SB  - IM
MH  - Humans
MH  - *Diabetes Mellitus, Type 2/blood/therapy
MH  - Male
MH  - Female
MH  - Middle Aged
MH  - *Glycemic Control/methods
MH  - *Glycated Hemoglobin/analysis
MH  - *Text Messaging
MH  - Aged
MH  - Blood Glucose/analysis
MH  - Social Networking
MH  - Self-Management/methods
MH  - Blood Glucose Self-Monitoring/methods
MH  - Cell Phone
MH  - Adult
PMC - PMC11066440
OTO - NOTNLM
OT  - Diabetes mellitus, type 2
OT  - Glycated hemoglobin
OT  - Randomized controlled trial
OT  - Social networking site
COIS- CONFLICTS OF INTEREST Jae Hyoung Cho is the CEO of the iKooB Inc.
EDAT- 2023/12/27 00:41
MHDA- 2024/05/02 06:42
PMCR- 2024/04/01
CRDT- 2023/12/26 20:39
PHST- 2023/10/30 00:00 [received]
PHST- 2023/12/21 00:00 [accepted]
PHST- 2024/05/02 06:42 [medline]
PHST- 2023/12/27 00:41 [pubmed]
PHST- 2023/12/26 20:39 [entrez]
PHST- 2024/04/01 00:00 [pmc-release]
AID - EnM.2023.1871 [pii]
AID - enm-2023-1871 [pii]
AID - 10.3803/EnM.2023.1871 [doi]
PST - ppublish
SO  - Endocrinol Metab (Seoul). 2024 Apr;39(2):344-352. doi: 10.3803/EnM.2023.1871. 
      Epub 2023 Dec 27.